We have held our first digital event!

On 2nd and 4th June, we broadcasted two live webinar days on Ovine Respiratory Complex online.

The webinars were taught by the speakers Christian de la Fe and José María González, who are ovine sector opinion leaders. Moreover, they were moderated by Raúl Martínez, a Syva ruminant technician.

The topics tackled were ‘Mycoplasma and Ovine Respiratory Pathology: Coherent Use of Antimicrobials’ and ‘Ovine Respiratory Complex: From Epidemiology to Prevention’.

This new digital format has enabled us to reach a very large number of people. More than 400 professionals from the ovine sector in Spain and Portugal have signed up for our event.

Both sessions had a very high level of specialized technical content. They were very interactive, interesting and dynamic for attendees.

We remind all those who signed up previously that the speaker recordings can be viewed until 12th July:https://syvawebseminar.com/

You may also be interested in

30 January, 2025

Syvac® EH Marker, the first and only DIVA vaccine against EHD, is now authorized in Belgium

Syva is pleased to announce that the FAMHP/FAGG has granted emergency use authorization for its marker (DIVA) vaccine against EHD in accordance with Article 110(2) of Regulation (EU) 2019/6 for use in cattle and deer.

Read more

24 January, 2025

Call for the 28th edition of the Syva Award International for the best doctoral thesis in Animal Health

We are pleased to remind you that the call for applications for the 28th Syva Award International is open until 18 February 2025. We also remind you that for two years now, the Syva Award International is no longer limited to Spanish candidates, but invites all doctoral students of any nationality who have submitted their thesis in animal health...

Read more

22 January, 2025

Syva receives a positive opinion for Syvazul BTV 3 vaccine from the CVMP of the European Medicines Agency (EMA).

On 15 January 2025, the Committee for Medicinal Products for Veterinary Use (CVMP) issued a positive opinion recommending the granting of a marketing authorization for Syvazul BTV 3 vaccine. This step forward marks an important milestone in the fight against Bluetongue, and Syva is proud to be at the forefront of this innovation.

Read more